NCT04741997 2026-03-02Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase EARLY_PHASE1 Recruiting50 enrolled